Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
764
-
Total 13F shares, excl. options
-
317M
-
Shares change
-
+15.3M
-
Total reported value, excl. options
-
$11.3B
-
Value change
-
+$543M
-
Put/Call ratio
-
0.82
-
Number of buys
-
339
-
Number of sells
-
-374
-
Price
-
$35.69
Significant Holders of GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) as of Q1 2021
881 filings reported holding GSK - GLAXOSMITHKLINE PLC - SPONSORED ADR as of Q1 2021.
GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) has 764 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 317M shares
.
Largest 10 shareholders include Dodge & Cox (87.9M shares), Capital International Investors (19.9M shares), FMR LLC (17.1M shares), Fisher Asset Management, LLC (17M shares), PRICE T ROWE ASSOCIATES INC /MD/ (15.5M shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (10.2M shares), ROYAL BANK OF CANADA (9.76M shares), STATE STREET CORP (9.37M shares), RENAISSANCE TECHNOLOGIES LLC (8.76M shares), and Black Creek Investment Management Inc. (8.67M shares).
This table shows the top 764 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.